Gonadorelin
Also known as · GnRH · LHRH · Factrel
Overview
The native hypothalamic decapeptide that stimulates pituitary LH and FSH release. Its very short half-life means pulsatile administration preserves the physiological signal.
Research profile · for clinicians
Based on research: long-established clinically as a diagnostic agent and, via pump delivery, as fertility treatment in hypothalamic hypogonadism. Widely studied as an alternative to hCG for maintaining testicular function.
Mechanism of action
Pulsatile GnRH receptor activation stimulates gonadotrophs to release LH and FSH; continuous rather than pulsatile exposure downregulates the receptor and suppresses the axis instead.
Research record
- [01]Pulsatile pump delivery restores ovulation in hypothalamic amenorrhoea.
- [02]Continuous exposure causes axis suppression — the basis of GnRH-agonist therapy.
Selected references
Pulsatile GnRH therapy in hypogonadotropic hypogonadism
J. Clin. Endocrinol. Metab., 1985
Research deep dive
Every cited study, explained
Plain-language walkthroughs of each reference, with direct PubMed links and dosing-literature context.